Sam Azer: The Link Between Endometriosis and AMH
Sam Azer, Gynecologist at Links Medical, shared a post on LinkedIn:
“Understanding the Link Between Endometriosis and AMH
For many women living with endometriosis, concerns about long-term fertility are paramount. A key tool in assessing reproductive health is testing Anti-Müllerian Hormone (AMH) levels. AMH offers a snapshot of ovarian reserve, indicating the remaining supply of eggs in the ovaries.
Research shows that endometriosis, especially when ovarian cysts (endometriomas) are present or following their surgical removal, can result in decreased AMH levels. It is important to note that a lower AMH result does not equate to a diagnosis of infertility; instead, it serves as a data point to help tailor treatment plans.
Whether considering egg freezing, IVF, or natural conception, understanding AMH levels enables proactive and strategic approaches to preserving fertility potential.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Feb 13, 2026, 10:20Reproductive Outcomes for Same-Sex Couples Explored – JAMA
-
Feb 12, 2026, 15:16Exploring Expanded Carrier Screening for Pregnancy Health – Fertility and Sterility
-
Feb 12, 2026, 15:14Horace Roman: IFEM Endo Launches Masterclass for Endometriosis Surgeons in India
-
Feb 12, 2026, 15:12Nicolas Gatimel: Enhancing Reproductive Health Through Physical Activity
-
Feb 12, 2026, 15:10Adela Serban։ Elevate Your Gynecologic Ultrasound Skills in ART Procedures
-
Feb 12, 2026, 15:08Enhancing Fertility Awareness Through Community-Centered Initiatives – Fertility and Sterility
-
Feb 12, 2026, 14:11Discover Notable Papers in the Latest RBMO Digest Edition – RBMO
-
Feb 12, 2026, 13:18Christopher Robinson: Managing Impacted Fetal Head During Cesarean
-
Feb 12, 2026, 02:24Carrier Screening and Infertility Testing Through the Lens of GenEthics – ESHRE SIG Psychology and Counselling